Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o., zagreb - oksimetar za mjerenje koncentracije kisika

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o., zagreb - torakalni kateteri

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o., zagreb - drenaže tjelesnih šupljina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o., zagreb - ventilacija pacijenata s ovlaživanjem zraka

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

hra pharma rare diseases, 200 avenue de paris, chatillon, francuska - metirapon - kapsula, meka - 250 mg - urbroj: jedna kapsula sadrži 250 mg metirapona

Europska Unija - hrvatski - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirusni lijekovi za sustavnu uporabu - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 i 5. tecovirimat siga should be used in accordance with official recommendations.

Europska Unija - hrvatski - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunološke za suidae - svinja (za tov) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Europska Unija - hrvatski - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svinje - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Europska Unija - hrvatski - EMA (European Medicines Agency)

pharmsure veterinary products europe ltd - soj mycoplasma synoviae ms-h - imunomodulatori za ptice, živih bakterijskih cjepiva - piletina - za aktivne imunizacije budućnost roditeljskog jata tovnih pilića, budućnost sloj uzgajivač kokoši i pilića budućnost sloj za smanjenje sac zraka osipa i smanjiti broj jaja s anomalija jajeta obrazovanja, uzrokovane mycoplasma synoviae.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

zada pharmaceuticals d.o.o. - метопролол - tableta - 50 mg/1 tableta - 1 tableta sadrži: 50 mg metoprolol tartarata